Evidence map›Paper›PMID 17026767›Full record

ArticleBMC evolutionary biology2006

Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.

Richard A Stein, James V Staros

Open access · goldAbstract read
In one paragraph

Article in BMC evolutionary biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Amphiregulin and Fibrosis: Existing Evidence and Future Directions.International journal of molecular sciences · 2025
    Review
  3. IGEG-2 is amicroPublication biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Richard A SteinDept. of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA. richard.a.stein@vanderbilt.edu
James V Staros
Stony Brook University · USVanderbilt University · US

Funding

SPECTROSCOPIC STUDIES OF EGF RECEPTOR INTERACTIONSR01GM055056 · NIGMS · VANDERBILT UNIVERSITY · PI BETH, ALBERT H · 1997 to 2006
$1.5M
NIGMS NIH HHS R01 GM055056NIGMS NIH HHS R01 GM55056
6 · The paper itself

Abstract

backgroundIn the time since we presented the first molecular evolutionary study of the ErbB family of receptors and the EGF family of ligands, there has been a dramatic increase in genomic sequences available. We have utilized this greatly expanded data set in this study of the ErbB family of receptors and their ligands.

resultsIn our previous analysis we postulated that EGF family ligands could be characterized by the presence of a splice site in the coding region between the fourth and fifth cysteines of the EGF module and the placement of that module near the transmembrane domain. The recent identification of several new ligands for the ErbB receptors supports this characterization of an ErbB ligand; further, applying this characterization to available sequences suggests additional potential ligands for these receptors, the EGF modules from previously identified proteins: interphotoreceptor matrix proteoglycan-2, the alpha and beta subunit of meprin A, and mucins 3, 4, 12, and 17. The newly available sequences have caused some reorganizations of relationships among the ErbB ligand family, but they add support to the previous conclusion that three gene duplication events gave rise to the present family of four ErbB receptors among the tetrapods.

conclusionThis study provides strong support for the hypothesis that the presence of an easily identifiable sequence motif can distinguish EGF family ligands from other EGF-like modules and reveals several potential new EGF family ligands. It also raises interesting questions about the evolution of ErbB2 and ErbB3: Does ErbB2 in teleosts function differently from ErbB2 in tetrapods in terms of ligand binding and intramolecular tethering? When did ErbB3 lose kinase activity, and what is the functional significance of the divergence of its kinase domain among teleosts?

Indexed as

Evolution, MolecularAmino Acid MotifsAmino Acid SequenceAnimalsEpidermal Growth FactorErb-b2 Receptor Tyrosine KinasesErbB ReceptorsHumansLigandsMolecular Sequence DataPhylogenyProtein Structure, TertiaryReceptor, ErbB-3Receptor, ErbB-4RNA Splice SitesSequence AlignmentEpidermal Growth FactorErb-b2 Receptor Tyrosine KinasesERBB4 protein, humanErbB ReceptorsLigandsReceptor, ErbB-3Receptor, ErbB-4RNA Splice Sites

Identifiers

PMID17026767
PMCPMC1618406
OpenAlexW2159334756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.